| | | | | | Product | Package Size | EFP | CP | SB | DC | Composition | Registr. Holder | Category | | |
|---|
| What is an ATC-Code? | ATC-Overview |
|
| | | IP | CI | | Azyter | 6 x 0.25 g | 6.52 | 16.30 | 10 % | | Eye drops: Azithromycinum Dihydricum 3.75 mg | THEA Pharma S.A. | A / SL | FB | G |
|
| | | IP | | | Aprokam | Durchstechflasche(n) | | | k.A. | | poudre pour solution injectable: Cefuroximum 50 mg | THEA Pharma S.A. | A | FB | G |
| | | IP | | | Aprokam | 10 Durchstechflasche(n) | | | k.A. | | poudre pour solution injectable: Cefuroximum 50 mg | THEA Pharma S.A. | A | FB | G |
| | | IP | | | Aprokam | 10 | | | k.A. | | poudre pour solution injectable: Cefuroximum 50 mg | THEA Pharma S.A. | A | FB | G |
|
| | | IP | CI | | AciVision 30 mg/g | 4.5 g | 9.69 | 26.95 | 10 % | | Ophtalmic ointment: Aciclovirum 30 mg | OmniVision AG | A / SL | FB | G |
| | | IP | CI | | Virupos 30 mg/g | 4.5 g | 10.41 | 27.75 | 10 % | | Ophtalmic ointment: Aciclovirum 30 mg | URSAPHARM Schweiz
GmbH | A / SL | FB | G |
| | | IP | | | Xorox 30 mg/g | 4.5 g | 10.30 | 27.60 | 10 % | | Ophtalmic ointment: Aciclovirum 30 mg | AGEPHA PHARMA s.r.o.,
Bratislava,
Zweigniederlassung Zug | A / SL | FB | G |
|
| | | IP | CI | | Posiformin 2 % | 5 g | 4.66 | 9.45 | k.A. | | Ophtalmic ointment: Bibrocatholum 20 mg | URSAPHARM Schweiz
GmbH | B | FB | G |
|
| | | IP | CI | | Ciloxan | tube(s) à 3.5 g | 4.78 | 14.45 | 10 % | | Ophtalmic ointment: Ciprofloxacinum 3 mg | Novartis Pharma
Schweiz AG | A / SL | FB | G |
| | | IP | CI | | Ciloxan | 5 ml | 4.78 | 14.45 | 10 % | | Eye drops: Ciprofloxacinum 3 mg/ml | Novartis Pharma
Schweiz AG | A / SL | FB | G |
|
| | | IP | CI | | Dexafree UD 0,1% | 20 unidose(s) | 4.37 | 14.00 | 10 % | | Eye drops: Dexamethasoni Natrii Phosphas 1.093 mg/ml | THEA Pharma S.A. | A / SL | FB | G |
| | | IP | CI | | Maxidex | 5 ml | 3.41 | 12.95 | 10 % | | Eye drops: Dexamethasonum 1 mg | Novartis Pharma
Schweiz AG | ● A / SL | FB | G |
| | | IP | CI | | Spersadex mono 0.1% | 5 ml | 4.26 | 13.85 | 10 % | | Eye drops: Dexamethasoni Natrii Phosphas 1 mg/ml | OmniVision AG | A / SL | FB | G |
| L | | IP | | | Ozurdex | piece(s) | 951.69 | 1051.45 | 10 % | | intravitreales Implantat in Applikator: Dexamethasonum 700 µg | AbbVie AG | A / SL | FB | G |
| | | | | | Dexocol 1 mg/ml | 6 ml | | | k.A. | | collyre en solution: Dexamethasoni Dihydrogenophosphas 1 mg/ml | Horus Pharma Suisse SA | A | FB | G |
| | | | | | Dexocol 1 mg/ml | 3 x 6 ml | | | k.A. | | collyre en solution: Dexamethasoni Dihydrogenophosphas 1 mg/ml | Horus Pharma Suisse SA | A | FB | G |
|
| | | IP | CI | | Yellox | 5 ml | 5.88 | 15.65 | 10 % | | Eye drops: Bromfenacum | Bausch & Lomb Swiss AG | B / SL | FB | G |
|
| | | IP | CI | | Iopidine 0,5 % | 5 ml | 14.42 | 32.10 | 10 % | | Eye drops: Apraclonidinum 5 mg/ml | Essential Pharma
Switzerland GmbH | ● B / SL | FB | G |
| | | IP | CI | | Iopidine 1% | 2 unidose(s) | 7.22 | 17.10 | 10 % | | Eye drops (monodoses): Apraclonidinum 10 mg/ml | Essential Pharma
Switzerland GmbH | B / SL | FB | G |
| L | | IP | CI | | Iopidine 1% | 24 | 68.44 | 90.85 | 10 % | | Eye drops (monodoses): Apraclonidinum 10 mg/ml | Essential Pharma
Switzerland GmbH | B / SL | FB | G |
|
| | | IP | CI | | Alphagan | 5 ml | 7.92 | 17.85 | 10 % | | Eye drops: Brimonidini Tartras 2 mg/ml | AbbVie AG | B / SL / SO | FB | G |
| | | IP | CI | | Alphagan | 3 x 5 ml | 20.24 | 38.45 | 10 % | | Eye drops: Brimonidini Tartras 2 mg/ml | AbbVie AG | B / SL / SO | FB | G |
| | | IP | CI | | Brimo-Vision 2 mg/ml | 60 x 0.35 ml | 7.35 | 17.25 | 10 % | | Augentropfen Lösung im Einzeldosisbehältnis: Brimonidini Tartras 2 mg/ml | OmniVision AG | ● B / SL / SG | FB | G |
| | | IP | CI | | Brimo-Vision 2 mg/ml | 180 x 0.35 ml | 17.20 | 35.10 | 10 % | | Augentropfen Lösung im Einzeldosisbehältnis: Brimonidini Tartras 2 mg/ml | OmniVision AG | B / SL / SG | FB | G |
|
| | | IP | | | Miostat | 12 1 ampoule(s) à 1.5 ml | | | k.A. | | Injection solution: Carbacholum | Alcon Switzerland SA | ● B | FB | G |
|
| | | IP | CI | | Miochol E | 2 ml | | | k.A. | | Injection solution: Acetylcholini Chloridum 20 mg | Bausch & Lomb Swiss AG | B | FB | G |
|
| | | IP | CI | | Diamox | 500 mg | 12.36 | 29.85 | 10 % | | Dry substance: Acetazolamidum 500 mg | Advanz Pharma
Specialty Medicine
Switzerland GmbH | B / SL | FB | G |
| | | IP | CI | | Diamox - T | 25 Tablet(s) | 6.05 | 15.80 | 10 % | | Tablets: Acetazolamidum 250 mg | Advanz Pharma
Specialty Medicine
Switzerland GmbH | B / SL | FB | G |
| | | IP | CI | | Glaupax - T | 40 Tablet(s) | 7.61 | 17.50 | 10 % | | Tablets: Acetazolamidum 250 mg | OmniVision AG | B / SL | FB | G |
| | | IP | CI | | Glaupax - T | 100 Tablet(s) | 19.02 | 37.10 | 10 % | | Tablets: Acetazolamidum 250 mg | OmniVision AG | B / SL | FB | G |
| | | IP | CI | | Diamox Sustets | 30 Capsule(s) | 25.89 | 46.85 | k.A. | | Capsules: Acetazolamidum 500 mg | Corden Pharma
Fribourg SA | B | FB | G |
|
| | | IP | CI | | Azopt | 5 ml | 8.96 | 26.15 | 10 % | | | Novartis Pharma
Schweiz AG | B / SL | FB | G |
| | | IP | CI | | Azopt | 3 x 5 ml | 22.86 | 41.30 | 10 % | | | Novartis Pharma
Schweiz AG | B / SL | FB | G |
| | | | | | Brinzo-Vision 10 mg/ml | 5 ml | | | k.A. | | Augentropfensuspension: Brinzolamidum 10 mg/ml | OmniVision AG | B | FB | G |
| | | | | | Brinzo-Vision 10 mg/ml | 3 x 5 ml | | | k.A. | | Augentropfensuspension: Brinzolamidum 10 mg/ml | OmniVision AG | B | FB | G |
|
| | | IP | CI | | Simbrinza, Brinzolamid
10mg/ml | 5 ml | 15.32 | 33.10 | 10 % | | Brimonidintartrat: 2 Active Agents | Novartis Pharma
Schweiz AG | B / SL | FB | G |
| | | IP | CI | | Simbrinza, Brinzolamid
10mg/ml | 3 x 5 ml | 43.64 | 63.90 | 10 % | | Brimonidintartrat: 2 Active Agents | Novartis Pharma
Schweiz AG | B / SL | FB | G |
|
| | | IP | CI | | Betoptic-S | 5 ml | 4.51 | 14.15 | 10 % | | Eye drops: Betaxololum 2.5 mg/ml | Medius AG | B / SL | FB | G |
| | | IP | CI | | Betoptic-S | 3 x 5 ml | 11.50 | 28.90 | 10 % | | Eye drops: Betaxololum 2.5 mg/ml | Medius AG | B / SL | FB | G |
| | | IP | CI | | Betoptic-S Single Dose | 60 piece(s) | | 60.00 | k.A. | | | Medius AG | B | FB | G |
|
| | | IP | CI | | Arteoptic LA 2 % | 3 ml | 4.57 | 14.20 | 10 % | | Eye drops: Carteololi Hydrochloridum 20 mg/ml | Bausch & Lomb Swiss AG | ● B / SL | FB | G |
| | | IP | CI | | Arteoptic LA 2% UD | 30 1 unidose(s) à 0.2 ml | 6.74 | 16.55 | 10 % | | Eye drops: Carteololi Hydrochloridum 20 mg/ml | Bausch & Lomb Swiss AG | B / SL | FB | G |
| | | IP | CI | | Arteoptic LA 2 % | 3 x 3 ml | 11.70 | 29.15 | 10 % | | Eye drops: Carteololi Hydrochloridum 20 mg/ml | Bausch & Lomb Swiss AG | ● B / SL | FB | G |
| | | IP | CI | | Arteoptic 0,5 %,
Augentropfen | 5 ml | 6.60 | 15.80 | 10 % | | Carteololi Hydrochloridum 20 mg | Bausch & Lomb Swiss AG | B / SL | FB | G |
| | | IP | CI | | Arteoptic 0,5 %,
Augentropfen | 3 x 5 ml | 16.84 | 35.75 | k.A. | | Carteololi Hydrochloridum 20 mg | Bausch & Lomb Swiss AG | B | FB | G |
|
| | | IP | CI | | Elymbus 0.1 mg/g | 30 x 0.3 g | 15.87 | 33.70 | 10 % | | | THEA Pharma S.A. | B / SL | FB | G |
| | | IP | CI | | Elymbus 0.1 mg/g | 90 x 0.3 g | 45.23 | 65.60 | 10 % | | | THEA Pharma S.A. | B / SL | FB | G |
| | | IP | CI | | Lumigan, 0.1 mg/ml | 3 ml | 14.66 | 32.35 | 10 % | | Eye drops: Bimatoprostum | AbbVie AG | B / SL | FB | G |
| | | IP | CI | | Lumigan, 0.1 mg/ml | 3 x 3 ml | 41.16 | 61.20 | 10 % | | Eye drops: Bimatoprostum | AbbVie AG | B / SL | FB | G |
| | | IP | CI | | Lumigan 0,3 mg/ml Unit
Dose | 30 x 0.4 ml | 17.82 | 35.80 | 10 % | | Eye drops: Bimatoprostum | AbbVie AG | B / SL | FB | G |
| | | IP | CI | | Lumigan 0,3 mg/ml Unit
Dose | 90 x 0.4 ml | 50.80 | 71.65 | 10 % | | Eye drops: Bimatoprostum | AbbVie AG | B / SL | FB | G |
| | | IP | CI | | Bimatoprost Labatec 0.3
mg/ml | | | | k.A. | | collyre en solution: Bimatoprostum | Labatec Pharma SA | | FB | G |
|
| | | IP | CI | | Atropine 0,5 % SDU Faure | 4 x 5 unidose(s) | | 31.35 | k.A. | | Eye drops: Atropini Sulfas 5 mg/ml | THEA Pharma S.A. | ● B | FB | G |
| | | | | | Ryjunea 0.1 mg/ml | 2.5 ml | | | k.A. | | collyre en solution: Atropini Sulfas | Santen SA | B | FB | G |
| | | | | | Ryjunea 0.1 mg/ml | 3 x 2.5 ml | | | k.A. | | collyre en solution: Atropini Sulfas | Santen SA | B | FB | G |
| | | IP | CI | | Skiatropin 0 | 4 ml | 2.85 | 6.85 | k.A. | | Eye drops: Atropini Sulfas 3 mg | Chauvin Novopharma AG | B | FB | G |
|
| | | IP | | | Cyclogyl 0,5 % | 10 ml | | 25.30 | k.A. | | Eye drops: Cyclopentolati Hydrochloridum 5 mg/ml | Alcon Switzerland SA | B | FB | G |
| | | IP | | | Cyclogyl 1 % | 10 ml | | 25.30 | k.A. | | Eye drops: Cyclopentolati Hydrochloridum 10 mg/ml | Alcon Switzerland SA | B | FB | G |
|
| | SIP | IP | CI | | Relestat | 5 ml | 7.15 | 17.00 | 10 % | | Eye drops: Epinastini Hydrochloridum | AbbVie AG | B / SL | FB | G |
|
| | | IP | CI | | Allergo-COMOD | 10 ml | 6.00 | 11.10 | 10 % | | Eye drops: Natrii Cromoglicas 20 mg/ml | URSAPHARM Schweiz
GmbH | D / SL / SG | FB | G |
| | | IP | CI | | Opticrom-Allergo | 20 x 0.3 ml | | | k.A. | | Augentropfen in Ampullen: Natrii Cromoglicas 20 mg/ml | Spirig HealthCare AG | D | FB | G |
| | | IP | CI | | Opticrom-Allergo | 40 x 0.3 ml | | | k.A. | | Augentropfen in Ampullen: Natrii Cromoglicas 20 mg/ml | Spirig HealthCare AG | D | FB | G |
|
| | | IP | CI | | Allergodil | 6 ml | 5.99 | 15.75 | 10 % | | Eye drops: Azelastini Hydrochloridum | VERFORA SA | B / SL | FB | G |
| | | IP | CI | | Allergodil saisonal | 4 ml | | | k.A. | | Eye drops: Azelastini Hydrochloridum | VERFORA SA | D | FB | G |
|
| | | IP | CI | | BILAXIN Ophta 6 mg / ml | 5 ml | | | k.A. | | Eye drops: Bilastinum 6 mg/ml | A. Menarini GmbH | D | FB | G |
|
| | | IP | | | VISICLOR 30 mg/g | 0.8 g | | | k.A. | | | Sintetica SA | B | FB | G |
| | | IP | | | VISICLOR 30 mg/g | 10 x 0.8 g | | | k.A. | | | Sintetica SA | B | FB | G |
| | | IP | | | VISICLOR 30 mg/g | 20 x 0.8 g | | | k.A. | | | Sintetica SA | B | FB | G |
| | | IP | | | VISICLOR 30 mg/g | 50 x 0.8 g | | | k.A. | | | Sintetica SA | B | FB | G |
|
| L | | IP | | | Eylea, 2 mg/0,05 ml | Durchstechflasche(n) | 500.00 | 563.25 | 10 % | | Injection solution: Afliberceptum 2mg / 0.05ml | Bayer (Schweiz) AG | B / SL / SO | FB | G |
| L | | IP | | | Eylea 2 mg/0.05 ml | | 500.00 | 563.25 | 10 % | | Lösung zur intravitrealen Injektion in einer Fertigspritze: Afliberceptum 2mg / 50µl | Bayer (Schweiz) AG | B / SL / SO | FB | G |
| L | | IP | | | Mynzepli 40 mg/ml | | 417.33 | 478.45 | 10 % | | Injection solution: Afliberceptum 2mg / 0.05ml | Advanz Pharma
Specialty Medicine
Switzerland GmbH | B / SL / SG | FB | G |
| L | | IP | | | Pavblu 40 mg/ml | | 417.33 | 478.45 | 10 % | | Injection solution: Afliberceptum 2mg / 0.05ml | Amgen Switzerland AG | B / SL / SG | FB | G |
| L | | IP | | | Afqlir 40 mg/ml | | 417.33 | 478.45 | 10 % | | Injection solution in prefilled syringe: Afliberceptum 2mg / 50µl | Sandoz
Pharmaceuticals AG | B / SL / SG | FB | G |
| L | | | | | Ahzantive 2 mg/0.05 ml | | 417.33 | 478.45 | 10 % | | Injection solution in prefilled syringe: Afliberceptum 2mg / 0.05ml | Medvisis Switzerland AG | B / SL / SG | FB | G |
| L | | IP | | | Mynzepli 40 mg/ml | | 417.33 | 478.45 | 10 % | | Injection solution in prefilled syringe: Afliberceptum 2mg / 0.05ml | Advanz Pharma
Specialty Medicine
Switzerland GmbH | B / SL / SG | FB | G |
| L | | IP | | | Pavblu 40 mg/ml | | 417.33 | 478.45 | 10 % | | Injection solution in prefilled syringe: Afliberceptum 2mg / 0.05ml | Amgen Switzerland AG | B / SL / SG | FB | G |
| L | | IP | | | Eylea 8 mg/0.07 ml | | 500.00 | 560.20 | 10 % | | Injection solution: Afliberceptum 8mg / 0.07ml | Bayer (Schweiz) AG | B / SL | FB | G |
| L | | IP | | | Eylea 8 mg/0.07ml | | 500.00 | 560.20 | 10 % | | Injection solution in prefilled syringe: Afliberceptum 8mg / 0.07ml | Bayer (Schweiz) AG | B / SL | FB | G |
| | | IP | | | Aflivis 40 mg/ml | | 417.33 | 478.45 | k.A. | | Injection solution: Afliberceptum 2mg / 50µl | OmniVision AG | B | FB | G |
| | | IP | | | Afqlir 40 mg/ml | | | | k.A. | | Injection solution: Afliberceptum 2mg / 0.05ml | Sandoz
Pharmaceuticals AG | B | FB | G |
| | | | | | Yesafili 40 mg/ml | | | | k.A. | | Injection solution: Afliberceptum 2mg / 0.05ml | Medius AG | B | FB | G |
| | | IP | | | Aflivis 40 mg/ml | | 417.33 | 478.45 | k.A. | | Injection solution in prefilled syringe: Afliberceptum 2mg / 50µl | OmniVision AG | B | FB | G |
| | | | | | Baiama 40 mg/ml | | | | k.A. | | Injection solution: Afliberceptum 2mg / 0.05ml | Horus Pharma Suisse SA | B | FB | G |
| | | | | | Eydenzelt 40 mg / ml | | | | k.A. | | Injection solution: Afliberceptum 2mg / 0.05ml | iQone Healthcare
Switzerland SA | B | FB | G |
| | | IP | | | Eylea 2 mg/0.05 ml | syringe(s) | 913.48 | 1063.35 | k.A. | | Lösung zur intravitrealen Injektion in einer Fertigspritze: Afliberceptum 2mg / 50µl | Bayer (Schweiz) AG | B | FB | G |
| | | | | | Eydenzelt 40mg / ml | | | | k.A. | | solution injectable en seringue préremplie: Afliberceptum 2mg / 0.05ml | iQone Healthcare
Switzerland SA | B | FB | G |
|
| L | | IP | | | Beovu 120mg/ml | | 652.91 | 726.50 | 10 % | | Injection solution in prefilled syringe: Brolucizumabum 120 mg/ml | Novartis Pharma
Schweiz AG | B / SL | FB | G |
|
| | | IP | CI | | Sérum autologue ICH 50% | 8 ml | | | k.A. | | Eye drops: Serum Humanum Autologum 4 ml | Institut Central des
Hôpitaux Hôpital du
Valais Site Sion | B | FB | G |
|
| | | IP | CI | | Oxervate | 7 | | | k.A. | | Eye drops: Cenegerminum | Dompé International SA | B | FB | G |
|
| | | | CI | H | Similasan Entzündete
Augen, Augentropfen 10 ml | 10 ml | | | k.A. | | 3 Active Agents | T&S Eye Care
Management AG | D | FB | G |
| | | | CI | H | Mucokehl D5 | 5 ml | | | k.A. | | Eye drops: Mucor Racemosus e Volumine Cellulae (Lyophil., Steril.) D5 Aquos (Hab 5B) | ebi-pharm ag | D | FB | G |
| | | | CI | H | Similasan Allergisch
reagierende Augen | 10 ml | | | k.A. | | Eye drops: 3 Active Agents | T&S Eye Care
Management AG | D | FB | G |
| | | | CI | H | Similasan Trockene Augen | 10 ml | | | k.A. | | Eye drops: 3 Active Agents | T&S Eye Care
Management AG | D | FB | G |
| | | | CI | | Similasan Überanstrengte
Augen N | 20 | | | k.A. | | Eye drops: 3 Active Agents | T&S Eye Care
Management AG | D | FB | G |
| | | | CI | | Similasan Allergisch
reagierende Augen N | 20 x 0.4 ml | | | k.A. | | Augentropfen Monodosen: 3 Active Agents | T&S Eye Care
Management AG | D | FB | G |
| | | | CI | | Similasan Entzündete
Augen N | 20 x 0.4 ml | | | k.A. | | Augentropfen Monodosen: 3 Active Agents | T&S Eye Care
Management AG | D | FB | G |
| | | | CI | | Similasan Trockene Augen N | 20 x 0.4 ml | | | k.A. | | Augentropfen Monodosen: 3 Active Agents | T&S Eye Care
Management AG | D | FB | G |
| | | | CI | H | Similasan Überanstrengte
Augen, Augentropfen 10 ml | 10 ml | | | k.A. | | Solution: 3 Active Agents | T&S Eye Care
Management AG | D | FB | G |
| | | | CI | H | Oculoheel | 20 x 0.45 ml | | | k.A. | | Augentropfen Monodosen: 4 Active Agents | ebi-pharm ag | D | FB | G |
